title: Narcolepsy associated with primary temporal lobe B-cells lymphoma in a HLA DR2 negative subject.
abstract: Narcolepsy and cataplexy began one year before treatment of a left mid-temporal primary B-cells lymphoma in a HLA DR2 negative man. Treatment with radio therapy and immunosuppression induced regression of the lymphoma and disappearance of narcolepsy and cataplexy.
authors.affiliation: Department of Neurology, State University of Chieti, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Onofrj
authors.forename: L
authors.initials: L
authors.lastname: Curatola
authors.forename: F
authors.initials: F
authors.lastname: Ferracci
authors.forename: T
authors.initials: T
authors.lastname: Fulgente
mesh_terms: D000328:Adult; D001932:Brain Neoplasms / Q000150:complications* / Q000503:physiopathology; D002385:Cataplexy / Q000209:etiology / Q000503:physiopathology; D004569:Electroencephalography; D015802:HLA-DR2 Antigen / Q000032:analysis*; D006801:Humans; D016393:Lymphoma, B-Cell / Q000150:complications* / Q000503:physiopathology; D008297:Male; D009290:Narcolepsy / Q000209:etiology* / Q000503:physiopathology; D011930:Reaction Time / Q000502:physiology; D012895:Sleep, REM / Q000502:physiology; D013702:Temporal Lobe / Q000503:physiopathology; D014057:Tomography, X-Ray Computed
chemical_list: D015802:HLA-DR2 Antigen